Fifth Third Bancorp’s CorMedix CRMD Stock Holding History

Fifth Third Bancorp’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.51K	Hold	320	–	–	﹤0.01%	4058
2026 Q1	$2.17K	Buy	+320	New	+$2.37K	﹤0.01%	4018

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Fifth Third Bancorp's CRMD Position: Q2 2026 in Review

Fifth Third Bancorp held its CorMedix (CRMD) position steady in Q2 2026 at 320 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4058.

Fifth Third Bancorp first reported a position in CRMD in Q1 2026 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Fifth Third Bancorp held 320 shares of CorMedix worth $2.51K as of Q2 2026.
Fifth Third Bancorp left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4058 holding.
Fifth Third Bancorp first reported a position in CorMedix in Q1 2026 and has held it in 2 quarters since.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.